JPMorgan downgrades Fisher&Paykel Healthcare to 'underweight' with a price target of AUD23.20

  • Investing.com
JPMorgan downgrades Fisher&Paykel Healthcare to 'underweight' with a price target of AUD23.20

An analyst from JPMorgan downgraded Fisher&Paykel Healthcare (ASX: FPH ) from 'neutral' to 'underweight' with a price target of AUD23.20 from a prior price target of AUD23.70.

Prior to this rating, Fisher&Paykel Healthcare had 1 buy ratings, 3 hold ratings, and 2 sell ratings.

For consensus analyst estimates and price targets on Fisher&Paykel Healthcare, click here. For more news on Fisher&Paykel Healthcare, click here.

Fisher&Paykel Healthcare's stock price closed at $24.83. They are down -1.86% in the last month and up 30.27% in the last 12 months.

According to Investing Pro, Fisher&Paykel Healthcare's fair value is $19.95, a downside of 21.32%. Fisher&Paykel Healthcare's fair value comes with a low degree of uncertainty, according to InvestingPro.

Check out Fisher&Paykel Healthcare's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100